Skip to main content
OPCHOption Care Health, Inc.Sell5.1·$23.48-0.63%
SellModerate Confidence
Investment thesis

Option Care Health offers attractive valuation and consistent earnings execution, but heavy customer and supplier concentration alongside declining earnings estimates and a confirmed downtrend keep the risk profile elevated.

Thesis pillars

  • Attractive Valuation EntryImproving
  • Customer Concentration RiskDeteriorating
  • Earnings Estimates DecliningDeteriorating
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Option Care Health, Inc. (OPCH) Stock Analysis

SellValueModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. At $23.48, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors.

Option Care Health operates 196 home and alternate-site infusion pharmacies in 43 states—87 full-service pharmacies plus 109 stand-alone ambulatory infusion suites—delivering anti-infective, immunoglobulin, and biologic therapies under physician direction. Revenue comes from... Read more

$23.48+5.9% A.UpsideScore 5.1/10#31 of 35 Medical Care Facilities
QualityF-score6 / 9FCF yield7.28%
Stop $22.50Target $24.87(analyst − 13%)A.R:R 1.2:1
Analyst target$28.58+21.7%12 analysts
$24.87our TP
$23.48price
$28.58mean
$39

Sell if holding. At $23.48, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.1/10, moderate confidence.

Passes 5/9 gates (clean insider activity, news events none recent, earnings proximity 46d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-09-13
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Oct 29, 202646d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Concentration risk — Customer: MCOs and non-governmental payers (88.0%)
Concentration risk — Supplier: four vendors
Thin upside margin: 5.9%

Key Metrics

P/E (TTM)17.9
P/E (Fwd)11.3
Mkt Cap$3.5B
EV/EBITDA11.3
Profit Mgn3.7%
ROE16.0%
Rev Growth1.9%
Beta0.61
DividendNone
Rating analysts19

Quality Signals

Piotroski F6/9

Options Flow

P/C0.10bullish
IV117%elevated

Concentration Risks(10-K Item 1A)

  • HIGHCustomerMCOs and non-governmental payers88%
    10-K Item 1A: '88% of our revenue came from MCOs and other non-governmental payers'
  • LOWCustomerlargest payer14%
    10-K Item 1: 'The Company's largest payer represented approximately 14% of its revenue for the year ended December 31, 2025.'
  • LOWregulatoryMedicare and Medicaid12%
    10-K Item 1: 'approximately 12% of the Company's revenue was reimbursable through direct government healthcare programs, such as Medicare and Medicaid.'
  • HIGHSupplierfour vendors
    10-K Item 1A: 'approximately 68% of our pharmaceutical and medical supply purchases were from four vendors'

Material Events(8-K, last 90d)

  • 2026-05-05Item 5.02LOW
    Chief Growth Officer Christopher L. Grashoff to depart effective May 8, 2026. Entitled to separation benefits under the Amended and Restated Executive Severance Plan conditioned on release of claims. No successor named.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Macd
2.1
Ma Position
3.0
Volume
3.7
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA, MA slope -2.2%/30d — confirmed downtrend

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.0
Earnings Growth
4.6
GatesMomentum 2.9<4.5A.R:R 1.2 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 46d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
46 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $22.97Resistance $24.52

Price Targets

$23
$25
A.Upside+5.9%
A.R:R1.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! momentum at 2.9 (below the engine's 4.5 threshold)
! asymmetry at 1.2 (below the engine's 1.5 threshold)@spot
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-10-29 (46d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is OPCH stock a buy right now?

Sell if holding. At $23.48, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $22.50. Score 5.1/10, moderate confidence.

What is the OPCH stock price target?

Take-profit target: $24.87 (+5.9% upside). Prior stop was $22.50. Stop-loss: $22.50.

What are the risks of investing in OPCH?

Concentration risk — Customer: MCOs and non-governmental payers (88.0%); Concentration risk — Supplier: four vendors; Thin upside margin: 5.9%.

Is OPCH overvalued or undervalued?

Option Care Health, Inc. trades at a P/E of 17.9 (forward 11.3). TrendMatrix value score: 7.3/10. Verdict: Sell.

What do analysts say about OPCH?

19 analysts cover OPCH with a consensus score of 3.9/5. Average price target: $29.

What does Option Care Health, Inc. do?Option Care Health operates 196 home and alternate-site infusion pharmacies in 43 states—87 full-service pharmacies...

Option Care Health operates 196 home and alternate-site infusion pharmacies in 43 states—87 full-service pharmacies plus 109 stand-alone ambulatory infusion suites—delivering anti-infective, immunoglobulin, and biologic therapies under physician direction. Revenue comes from reimbursements by MCOs, Medicare, Medicaid, and commercial payers for pharmaceuticals dispensed and nursing services, with 6,528 full-time and 1,738 part-time employees at year-end 2025.

Related stocks: SRTA (Strata Critical Medical, Inc.) · ASTH (Astrana Health Inc.) · INNV (InnovAge Holding Corp.) · STLN (Starling Oncology, Inc.) · GMRS (GMR Solutions Inc.)
Home Stocks OPCH

Latest news

Latest News

TradingKey46d ago
GuruFocus136d ago
Yahoo Finance137d agoEarnings
TipRanks137d ago
MarketBeat53d agoEarnings
MarketBeat53d ago
Cổng thông tin điện tử tỉnh Tây Ninh143d ago
Yahoo Finance144d ago
Yahoo Finance47d agoEarnings
MarketBeat47d ago
MarketBeat47d ago
Yahoo Finance145d agoEarnings
StockStory135d ago
Yahoo Finance136d agoEarnings
Finviz136d ago
GuruFocus136d ago
The Malone Telegram136d agoLegal
Quiver Quantitative136d ago
GlobeNewswire136d agoLegal
Seeking Alpha136d ago
Loading more...